- Home
- INMB vs CLST Comparison
INMB vs CLST Comparison
Compare INMB & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- CLST
- Stock Information
- Founded
- INMB 2015
- CLST 1922
- Country
- INMB United States
- CLST United States
- Employees
- INMB N/A
- CLST N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- CLST
- Sector
- INMB Health Care
- CLST
- Exchange
- INMB Nasdaq
- CLST Nasdaq
- Market Cap
- INMB 49.2M
- CLST 54.6M
- IPO Year
- INMB 2019
- CLST N/A
- Fundamental
- Price
- INMB $1.51
- CLST $14.88
- Analyst Decision
- INMB Hold
- CLST
- Analyst Count
- INMB 3
- CLST 0
- Target Price
- INMB $4.30
- CLST N/A
- AVG Volume (30 Days)
- INMB 363.1K
- CLST 9.8K
- Earning Date
- INMB 10-30-2025
- CLST 10-23-2025
- Dividend Yield
- INMB N/A
- CLST N/A
- EPS Growth
- INMB N/A
- CLST N/A
- EPS
- INMB N/A
- CLST 0.60
- Revenue
- INMB $50,000.00
- CLST $11,340,000.00
- Revenue This Year
- INMB $191.43
- CLST N/A
- Revenue Next Year
- INMB $12,299.51
- CLST N/A
- P/E Ratio
- INMB N/A
- CLST $25.20
- Revenue Growth
- INMB 19.05
- CLST 133.67
- 52 Week Low
- INMB $1.38
- CLST $10.67
- 52 Week High
- INMB $11.64
- CLST $15.30
- Technical
- Relative Strength Index (RSI)
- INMB 37.63
- CLST 69.68
- Support Level
- INMB $1.38
- CLST $14.72
- Resistance Level
- INMB $1.62
- CLST $15.00
- Average True Range (ATR)
- INMB 0.10
- CLST 0.32
- MACD
- INMB 0.00
- CLST 0.02
- Stochastic Oscillator
- INMB 32.41
- CLST 97.84
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.